US Food and Drug Administration regulatory updates in neuro-oncology
ConclusionsDespite the challenges of the past year brought on by the COVID-19 pandemic, progress continues to be made in neuro-oncology. These include first-of-their-kind FDA approvals and Guidances that are relevant to the management of patients with nervous system tumors.
Source: Journal of Neuro-Oncology - Category: Cancer & Oncology Source Type: research
More News: Brain | Brain Cancers | Breast Cancer | Cancer | Cancer & Oncology | Child Development | Children | Clinical Trials | COVID-19 | HER2 | Lung Cancer | Lymphoma | Neurofibromatosis | Neurology | Non-Small Cell Lung Cancer | Pandemics